India joins the global race for Vaccine production, mass Clinical trials for Coronavirus vaccine begin in Germany and UK!


The ongoing researches around the world are currently focussing on eradicating Coronavirus. But this procedure has suddenly gained speed as Germany and the UK declare mass human trials for the Coronavirus vaccine. Though there are around 155 projects worldwide that focus on the SARS-CoV-2 virus, Germany and the UK still top the list. This is because they are one of the only 5 countries which have approved human trials.

But the Asian subcontinent of India will also play a vital role in this battle. This is because of the countries low-cost production of pharmaceutical products. India’s foreign ambassador in the US, Taranjit Singh Sandhu says that India is ready to fight this pandemic along with the US.

Also Read: CDC gives false information about immunity of infants from Coronavirus, US reports multiple cases of infant COVID-19 infection

India is currently one of the world’s largest anti-malaria drug producers. This is because of the country’s high population. With a headcount of almost 1.5 billion people, India produces a lot of hydroxychloroquine in a year. A report released by FDA lists hydroxychloroquine as a potential Coronavirus treatment drug. WHO currently lists 6 vaccines in its mass human trials.

Germany takes an important decision on the Coronavirus vaccine along with the UK!

In Germany, a new vaccine with the name of “Biontech” has been approved for mass human trials. This is a significant step for humanity all over the world. Because this will help understand the effects soon and will help make a final vaccine very fast. In the first phase of the clinical trial, almost 2000 people are given the vaccine.

Also Read: Is the Coronavirus lockdown good for us? Lets talk about nature on this Earth Day, while our planet breathes fresh air!

Many more clinical trials are on the plan in Germany over the next few weeks. In the United Kingdom, the University of Oxford will carry out a mass trial on 24 April 2020. The government hopes to approve further testing if this trial brings positive results.

Let us know what you think about these countries’ decisions in the comments below.

1 thought on “India joins the global race for Vaccine production, mass Clinical trials for Coronavirus vaccine begin in Germany and UK!”

Leave a Comment